Atilotrelvir

阿泰特韦

Report date: 2025/08/07 17:04:56
NME

Base Information

Drug NameAtilotrelvir
Drug Alias Name泰阿特韦GST-HG171
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSARS-CoV-2-3C-like-proteinase inhibitors
TargetsSARS-CoV-2-3C-like-proteinase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFujian Guangsheng Zhonglin Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFujian Guangsheng Zhonglin Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A